AdisInsight Offers Single Point of Access to Entire Drug Lifecycle
Jinfo Blog
19th March 2015
Abstract
AdisInsight is a new platform developed by Springer that offers quick and easy search into more than 210,000 scientifically curated records. The platform allows access to well-structured information pertaining to the entire drug lifecycle, thus, rendering the platform as a "one stop solution" for organisations working across the healthcare spectrum.
Item
As a drug moves from laboratory to market, an enormous amount of information is generated at each stage that may be relevant to organisations for their competitive intelligence initiatives. Thus, organisations and professionals are expected to be at the top of these developments.
However, wading through this information jungle to glean the required pieces is an uphill task, and requires significant investment of time on a continual basis to check the comprehensiveness and scientific veracity of the data.
AdisInsight
Springer's AdisInsight is a new platform aimed at organisations and professionals who need quick and easy access to a database which has more than 210,000 scientifically curated records and the vendor advises to be updated daily. The platform is intuitive to use, has robust algorithms and several features which can save time and bring greater efficiency to the organisation.
While reviewing the AdisInsight platform, we were most impressed by the scientific strength of the records.
The write-ups, which we checked, were lucid but did not compromise on the scientific meaning and the correctness. The scientific terminologies were used as per the international code. Also, all write-ups were properly referenced with references hosted on Springer server, thus, taking away the fear of bumping into dead links.
This sits well with Springer's assertion that the AdisInsight team consists of highly qualified healthcare professionals who undergo a rigorous training programme.
We were also impressed with the way data was arranged in each record and the way that technology enabled easy navigation between different elements within a record. Furthermore, we found structural consistency between records useful.
Single Point of Access
Another aspect which is worth mentioning about the AdisInsight platform is its comprehensiveness. The platform offers a single point of access to more than 210,000 records across three content sets: drug-based clinical trials, global drug programmes, and pharmacovigilance insights (adverse drug reaction case reports, drug safety studies and regulatory news). We can say that one can find almost all relevant information related to a drug on this platform, thus taking away need to access multiple sites or databases.
The "autosuggestion" feature in the search box, check box filters to refine search results, and possibility to download retrieved results are other noticeable aspects of AdisInsight platform. In a nutshell, we can say the that intuitiveness and robustness of AdisInsight platform can be an enabling factor for professionals working in the healthcare domain.
Find Out More
Read FreePint's detailed Product Review of AdisInsight to get acquainted with the structure, functional aspects and promised business value of the AdisInsight platform.
- Blog post title: AdisInsight Offers Single Point of Access to Entire Drug Lifecycle
- Link to this page
- View printable version
- Product Review of AdisInsight (Customer Support; FreePint's View)
Friday, 13th March 2015 - Product Review of AdisInsight (Safety - Value Proposition and Competitor Landscape)
Thursday, 12th March 2015 - Product Review of AdisInsight (Drugs - Value Proposition and Competitor Landscape)
Monday, 9th March 2015 - Product Review of AdisInsight (Trials - Value and Competitor Landscape)
Friday, 27th February 2015 - Product Review of AdisInsight (Technology)
Monday, 23rd February 2015 - Product Review of AdisInsight (Safety - Content and Coverage)
Tuesday, 17th February 2015 - Product Review of AdisInsight (Drugs - Content and Coverage)
Tuesday, 10th February 2015 - Product Review of AdisInsight (Trials - Content and Coverage)
Thursday, 5th February 2015 - Product Review of AdisInsight (Introduction; Contact Details)
Tuesday, 3rd February 2015 - Specialist News Offerings - Pharma Sector
Wednesday, 10th December 2014 - Q&A with Adis Custom Intelligence Service - Bespoke Pharma Research & Analysis
Thursday, 16th October 2014
- Subscription Update for Pharmaceutical Companies
Monday, 26th January 2015 - Niche Data Visualisation Tools - FreePint for Biopharma
Friday, 21st November 2014
- Product Review of AdisInsight
Wednesday, 18th March 2015 - FreePint Report: Product Review of Cortellis
Tuesday, 22nd July 2014 - FreePint Report: Making Information Visible in Pharmaceutical Companies
Tuesday, 1st July 2014 - FreePint Report: Product Review of PharmaCircle
Thursday, 27th March 2014
Discussing news and AI strategies with the Financial Times
Community session
21st November 2024
2025 strategic planning; evaluating research reports; The Financial Times, news and AI
Blog posting
5th November 2024
November 2024 Update
YouTube video
7th November 2024
- 2025 strategic planning; evaluating research reports; The Financial Times, news and AI
5th November 2024 - All recent Jinfo Subscription content
31st October 2024 - End-user training best practice research
24th October 2024
- Jinfo Community session (TBC) (Community) 11th December 2024
- Discussing news and AI strategies with the Financial Times (Community) 21st November 2024
- Asia-Pacific Community session (Community) 19th November 2024